-
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.
-
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C.
Hepatol Commun. 2023 Apr 14;7(5):e0078.
Located in
Teams
/
VIDALAIN PO - VIRIMI
/
News
-
The broad viral inhibitors IFITMs can regulate Golgi trafficking
-
Li Zhong, Yuxin Song, Federico Marziali, Rustem Uzbekov, Xuan-Nhi Nguyen, Chloé Journo, Philippe Roingeard, Andrea Cimarelli
Located in
Teams
/
Cimarelli A - LP2L
/
News
-
CIRI group: Mathieu C - NITROVIRE
-
CIRI Group:
NeuroInvasion, TROpism and VIRal Encephalitis
Located in
Teams
-
Publication Equipe REVE. Manet et al. NAR
-
Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein.
Located in
Teams
/
Ohlmann T - REVE
/
News
-
A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors
-
Located in
Teams
/
VIDALAIN PO - VIRIMI
/
News
-
Research Projects - Axis 2 (PI: L. Etienne)
-
Functional evolution of virus-host interactions, and impact on cross-species transmissions
Located in
Teams
/
Cimarelli A - LP2L
-
Research Themes
-
The TEV (Translation of Eukaryotic and Viral mRNAs) is evolving into a new, bigger, team centred on the RNA and called REVE (RNA Expression in Viruses and Eukaryotes). Such a change is the result of the arrival of the EBV team of the CIRI.
You can follow us on Twitter @TEVteam.
Located in
Teams
/
Ohlmann T - REVE
-
Volchkov V - MBVP
-
Molecular Basis of Viral Pathogenicity
Located in
Teams
-
Vanhems P - PHE3ID
-
Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases
Located in
Teams
-
Ohlmann T - REVE
-
RNA Expression in Viruses and Eukaryotes
Located in
Teams
